A secure bathroom cabinet might sound like the safest place to store your medication, however according to experts keeping ...

Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...

Food poisoning, a common yet preventable health concern, continues to affect millions across the globe every year. Triggered by consuming contaminated food or beverages, this illness can range from ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

A new large-scale study led by researchers from Queen’s University has shown that combined wastewater testing and testing of ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants.

©News Group Newspapers Limited in England No. 679215 Registered office: 1 London Bridge Street, London, SE1 9GF. "The Sun", ...

Cocrystal Pharma’s CDI-988 shows promise as an antiviral treatment for new norovirus variants amid rising outbreak incidences.

In addition, Cocrystal is planning to initiate a human challenge study in norovirus-infected individuals to evaluate CDI-988 as a treatment and prophylaxis later in 2025.

Norovirus causes vomiting and diarrhea. It can spread through food, water, and surfaces touched by someone who has the virus. It usually gets better in 1 to 3 days.

Vaccine-In-A-Pill For Norovirus, The Infamous Winter Bug, Performs Well In Early Trials The trial targeted older adults, who are at risk of serious complications from the infection.

Their new study, published in Science Translational Medicine, identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly ...